Literature DB >> 11438654

The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair.

S Fan1, Y X Ma, M Gao, R Q Yuan, Q Meng, I D Goldberg, E M Rosen.   

Abstract

Hepatocyte growth factor (scatter factor) (HGF/SF) is a pleiotrophic mediator of epithelial cell motility, morphogenesis, angiogenesis, and tumorigenesis. HGF/SF protects cells against DNA damage by a pathway from its receptor c-Met to phosphatidylinositol 3-kinase (PI3K) to c-Akt, resulting in enhanced DNA repair and decreased apoptosis. We now show that protection against the DNA-damaging agent adriamycin (ADR; topoisomerase IIalpha inhibitor) requires the Grb2-binding site of c-Met, and overexpression of the Grb2-associated binder Gab1 (a multisubstrate adapter required for epithelial morphogenesis) inhibits the ability of HGF/SF to protect MDCK epithelial cells against ADR. In contrast to Gab1 and its homolog Gab2, overexpression of c-Cb1, another multisubstrate adapter that associates with c-Met, did not affect protection. Gab1 blocked the ability of HGF/SF to cause the sustained activation of c-Akt and c-Akt signaling (FKHR phosphorylation). The Gab1 inhibition of sustained c-Akt activation and of cell protection did not require the Gab1 pleckstrin homology or SHP2 phosphatase-binding domain but did require the PI3K-binding domain. HGF/SF protection of parental MDCK cells was blocked by wortmannin, expression of PTEN, and dominant negative mutants of p85 (regulatory subunit of PI3K), Akt, and Pak1; the protection of cells overexpressing Gab1 was restored by wild-type or activated mutants of p85, Akt, and Pak1. These findings suggest that the adapter Gab1 may redirect c-Met signaling through PI3K away from a c-Akt/Pak1 cell survival pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438654      PMCID: PMC87224          DOI: 10.1128/MCB.21.15.4968-4984.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Association of the multisubstrate docking protein Gab1 with the hepatocyte growth factor receptor requires a functional Grb2 binding site involving tyrosine 1356.

Authors:  L Nguyen; M Holgado-Madruga; C Maroun; E D Fixman; D Kamikura; T Fournier; A Charest; M L Tremblay; A J Wong; M Park
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

2.  Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis.

Authors:  K M Weidner; S Di Cesare; M Sachs; V Brinkmann; J Behrens; W Birchmeier
Journal:  Nature       Date:  1996-11-14       Impact factor: 49.962

3.  Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt.

Authors:  G Kulik; A Klippel; M J Weber
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 4.  PI3K: downstream AKTion blocks apoptosis.

Authors:  T F Franke; D R Kaplan; L C Cantley
Journal:  Cell       Date:  1997-02-21       Impact factor: 41.582

5.  Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes.

Authors:  L Amicone; F M Spagnoli; G Späth; S Giordano; C Tommasini; S Bernardini; V De Luca; C Della Rocca; M C Weiss; P M Comoglio; M Tripodi
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

6.  Efficient cellular transformation by the Met oncoprotein requires a functional Grb2 binding site and correlates with phosphorylation of the Grb2-associated proteins, Cbl and Gab1.

Authors:  E D Fixman; M Holgado-Madruga; L Nguyen; D M Kamikura; T M Fournier; A J Wong; M Park
Journal:  J Biol Chem       Date:  1997-08-08       Impact factor: 5.157

7.  Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor.

Authors:  M Holgado-Madruga; D K Moscatello; D R Emlet; R Dieterich; A J Wong
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

8.  Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation.

Authors:  P Rodriguez-Viciana; P H Warne; B Vanhaesebroeck; M D Waterfield; J Downward
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

9.  HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death.

Authors:  A Bardelli; P Longati; D Albero; S Goruppi; C Schneider; C Ponzetto; P M Comoglio
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

10.  A Grb2-associated docking protein in EGF- and insulin-receptor signalling.

Authors:  M Holgado-Madruga; D R Emlet; D K Moscatello; A K Godwin; A J Wong
Journal:  Nature       Date:  1996-02-08       Impact factor: 49.962

View more
  23 in total

1.  Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma.

Authors:  Gregory A Watson; Xinglu Zhang; Michael T Stang; Ryan M Levy; Pierre E Queiroz de Oliveira; William E Gooding; James G Christensen; Steven J Hughes
Journal:  Neoplasia       Date:  2006-11       Impact factor: 5.715

2.  C-Met inhibitor MK-8003 radiosensitizes c-Met-expressing non-small-cell lung cancer cells with radiation-induced c-Met-expression.

Authors:  Vikas Bhardwaj; Yanai Zhan; Maria Angelica Cortez; Kie Kian Ang; David Molkentine; Anupama Munshi; Uma Raju; Ritsuko Komaki; John V Heymach; James Welsh
Journal:  J Thorac Oncol       Date:  2012-08       Impact factor: 15.609

3.  The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells.

Authors:  James W Welsh; Daruka Mahadevan; Ron Ellsworth; Laurence Cooke; David Bearss; Baldassarre Stea
Journal:  Radiat Oncol       Date:  2009-12-22       Impact factor: 3.481

4.  miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222.

Authors:  M Acunzo; R Visone; G Romano; A Veronese; F Lovat; D Palmieri; A Bottoni; M Garofalo; P Gasparini; G Condorelli; M Chiariello; C M Croce
Journal:  Oncogene       Date:  2011-06-27       Impact factor: 9.867

5.  Thiosemicarbazones suppress expression of the c-Met oncogene by mechanisms involving lysosomal degradation and intracellular shedding.

Authors:  Kyung Chan Park; Bekesho Geleta; Lionel Yi Wen Leck; Jasmina Paluncic; Shannon Chiang; Patric J Jansson; Zaklina Kovacevic; Des R Richardson
Journal:  J Biol Chem       Date:  2019-11-19       Impact factor: 5.157

6.  Crosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancer.

Authors:  Yingqiu Xie; Wenfu Lu; Shenji Liu; Qing Yang; Brett S Carver; Estelle Li; Yuzhuo Wang; Ladan Fazli; Martin Gleave; Zhenbang Chen
Journal:  Mol Endocrinol       Date:  2014-08-06

Review 7.  MET receptor tyrosine kinase as an autism genetic risk factor.

Authors:  Yun Peng; Matthew Huentelman; Christopher Smith; Shenfeng Qiu
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

8.  Role of Src signal transduction pathways in scatter factor-mediated cellular protection.

Authors:  Saijun Fan; Qinghui Meng; John J Laterra; Eliot M Rosen
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

9.  Anti-apoptotic role of caspase-cleaved GAB1 adaptor protein in hepatocyte growth factor/scatter factor-MET receptor protein signaling.

Authors:  Arnaud Le Goff; Zongling Ji; Bérénice Leclercq; Roland P Bourette; Alexandra Mougel; Cateline Guerardel; Yvan de Launoit; Jérôme Vicogne; Gautier Goormachtigh; Véronique Fafeur
Journal:  J Biol Chem       Date:  2012-08-22       Impact factor: 5.157

10.  PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells.

Authors:  Hal E Crosswell; Anindya Dasgupta; Carlos S Alvarado; Tanya Watt; James G Christensen; Pradip De; Donald L Durden; Harry W Findley
Journal:  BMC Cancer       Date:  2009-11-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.